South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspen-p -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspen-p -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspen-p -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sonke -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - celecoxib -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - warfarin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - warfarin sodium -

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - probenecid 500mg;  ;  ;  ;  ; probenecid 500mg; probenecid 500mg - film coated tablet - 500 mg - active: probenecid 500mg         excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid active: probenecid 500mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid active: probenecid 500mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid - · probenecid is a uricosuric agent for the treatment of hyperuricaemia in all stages of gout and gouty arthritis except a presenting acute attack. asymptomatic hyperuricaemia seems to occur in a significant percentage of relatives of gouty patients. probenecid may be given prophylactically to these people to forestall gouty attacks and urate deposition in tissues. by virtue of its effective uricosuric activity, probenecid may be used to control the hyperuricaemia induced or aggravated by many diuretics employed for the treatment of oedema and hypertension (e.g. thiazides and similar diuretics).